Synovus Financial Corp Has $3.16 Million Stake in Cooper Companies Inc (COO)

Share on StockTwits

Synovus Financial Corp lessened its stake in shares of Cooper Companies Inc (NYSE:COO) by 6.5% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 10,675 shares of the medical device company’s stock after selling 748 shares during the period. Synovus Financial Corp’s holdings in Cooper Companies were worth $3,161,000 at the end of the most recent reporting period.

Other institutional investors also recently added to or reduced their stakes in the company. Dupont Capital Management Corp grew its position in Cooper Companies by 4.4% in the 4th quarter. Dupont Capital Management Corp now owns 881 shares of the medical device company’s stock valued at $224,000 after acquiring an additional 37 shares during the last quarter. Thrivent Financial for Lutherans grew its position in shares of Cooper Companies by 1.8% in the 4th quarter. Thrivent Financial for Lutherans now owns 2,141 shares of the medical device company’s stock valued at $545,000 after acquiring an additional 37 shares during the period. Oregon Public Employees Retirement Fund grew its position in shares of Cooper Companies by 0.8% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 5,360 shares of the medical device company’s stock valued at $1,364,000 after acquiring an additional 41 shares during the period. Raymond James Trust N.A. grew its position in shares of Cooper Companies by 5.4% in the 4th quarter. Raymond James Trust N.A. now owns 814 shares of the medical device company’s stock valued at $207,000 after acquiring an additional 42 shares during the period. Finally, Rehmann Capital Advisory Group grew its position in shares of Cooper Companies by 24.3% in the 4th quarter. Rehmann Capital Advisory Group now owns 220 shares of the medical device company’s stock valued at $56,000 after acquiring an additional 43 shares during the period. Institutional investors own 96.22% of the company’s stock.

In other Cooper Companies news, CFO Brian G. Andrews sold 1,648 shares of Cooper Companies stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $293.28, for a total value of $483,325.44. Following the completion of the sale, the chief financial officer now owns 1,101 shares in the company, valued at approximately $322,901.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Stanley Md Zinberg sold 740 shares of Cooper Companies stock in a transaction dated Monday, March 11th. The stock was sold at an average price of $290.03, for a total transaction of $214,622.20. Following the completion of the sale, the director now owns 17,421 shares of the company’s stock, valued at approximately $5,052,612.63. The disclosure for this sale can be found here. Insiders sold a total of 87,030 shares of company stock valued at $25,461,465 in the last quarter. Corporate insiders own 1.70% of the company’s stock.

Shares of NYSE COO traded down $0.71 during mid-day trading on Monday, reaching $291.22. 235,073 shares of the company were exchanged, compared to its average volume of 229,067. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.75 and a current ratio of 1.27. The stock has a market cap of $14.38 billion, a PE ratio of 25.32, a P/E/G ratio of 2.26 and a beta of 0.85. Cooper Companies Inc has a twelve month low of $221.50 and a twelve month high of $302.36.

Cooper Companies (NYSE:COO) last posted its earnings results on Tuesday, March 5th. The medical device company reported $2.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.50 by $0.38. The company had revenue of $628.10 million during the quarter, compared to analysts’ expectations of $618.50 million. Cooper Companies had a net margin of 14.22% and a return on equity of 17.56%. As a group, analysts predict that Cooper Companies Inc will post 12.01 EPS for the current fiscal year.

A number of brokerages have recently commented on COO. Zacks Investment Research downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Tuesday, May 7th. Jefferies Financial Group lifted their price objective on shares of Cooper Companies to $330.00 and gave the company a “buy” rating in a research report on Wednesday, March 6th. Wells Fargo & Co lifted their price objective on shares of Cooper Companies from $305.00 to $325.00 and gave the company an “outperform” rating in a research report on Wednesday, March 6th. Stephens lifted their price objective on shares of Cooper Companies from $305.00 to $320.00 and gave the company an “overweight” rating in a research report on Wednesday, March 6th. Finally, Raymond James lifted their price objective on shares of Cooper Companies from $300.00 to $325.00 and gave the company an “outperform” rating in a research report on Wednesday, March 6th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $307.90.

TRADEMARK VIOLATION WARNING: “Synovus Financial Corp Has $3.16 Million Stake in Cooper Companies Inc (COO)” was reported by Ticker Report and is owned by of Ticker Report. If you are accessing this report on another website, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://www.tickerreport.com/banking-finance/4354183/synovus-financial-corp-has-3-16-million-stake-in-cooper-companies-inc-coo.html.

Cooper Companies Company Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Recommended Story: Earnings Per Share (EPS)

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Autoliv  PT Lowered to $62.00 at Buckingham Research
Autoliv PT Lowered to $62.00 at Buckingham Research
Shotspotter  Cut to “Market Perform” at Northland Securities
Shotspotter Cut to “Market Perform” at Northland Securities
Buckingham Research Increases Sonic Automotive  Price Target to $20.00
Buckingham Research Increases Sonic Automotive Price Target to $20.00
Vail Resorts  Earns Market Perform Rating from Analysts at Wells Fargo & Co
Vail Resorts Earns Market Perform Rating from Analysts at Wells Fargo & Co
Johnson Outdoors  Downgraded by Sidoti
Johnson Outdoors Downgraded by Sidoti
Autoliv  Stock Rating Upgraded by Robert W. Baird
Autoliv Stock Rating Upgraded by Robert W. Baird


© 2006-2019 Ticker Report